Income Taxes - Additional Information (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Income Tax Contingency [Line Items] | |||
| Valuation allowance increased (decreased) value | $ 83 | $ 83 | |
| Liability related to uncertain tax positions | 0 | ||
| Reserve for unrecognized tax benefits | 19 | 13 | $ 8 |
| Interest or penalties accrued | 0 | $ 0 | |
| Unrecognized tax benefits that would impact effective tax rate | 0 | ||
| Federal | |||
| Income Tax Contingency [Line Items] | |||
| R&D costs amortization period | 5 years | ||
| Net operating loss carryforwards | 13 | ||
| Federal | Research | |||
| Income Tax Contingency [Line Items] | |||
| Research tax credits | 41 | ||
| Foreign Tax Jurisdiction | |||
| Income Tax Contingency [Line Items] | |||
| R&D costs amortization period | 15 years | ||
| Foreign Tax Jurisdiction | Research | |||
| Income Tax Contingency [Line Items] | |||
| Research tax credits | 3 | ||
| State | |||
| Income Tax Contingency [Line Items] | |||
| Net operating loss carryforwards | 34 | ||
| State | Research | |||
| Income Tax Contingency [Line Items] | |||
| Research tax credits | $ 20 | ||